Global Egg Phosphatidylcholine Market Overview

Egg Phosphatidylcholine Market was valued at USD 15392.48 million in 2023 and is expected to reach USD 26517.55 million by the year 2032, at a CAGR of 6.23%.

Egg phosphatidylcholine, an essential component of biological membranes, is derived from egg yolk through both chemical and mechanical extraction methods, often employing hexane as a solvent. Phosphatidylcholine is part of the broader class of phospholipids—lipid molecules that contain phosphorus and play critical roles in various biological functions. These phospholipids have garnered significant attention in recent years due to their unique biochemical properties, serving as signal transmitters, emulsifiers, messengers, and stabilizers across multiple industries. The versatility of phospholipids, especially phosphatidylcholine, has made them valuable in food, pharmaceuticals, and cosmetics.

• Phosphatidylcholine is one of the most common types of phospholipids and is typically sourced from soybeans and eggs. Its role as an emulsifier makes it a crucial ingredient in various applications, including food products, where it aids in texture and stability, and in pharmaceuticals and cosmetics, where it contributes to product consistency and enhances absorption. Phospholipids, as a group, are foundational to cell membrane structure, facilitating key biochemical processes essential to cellular function and signaling. Phosphatidylcholine, in particular, has been recognized for its role in maintaining cell integrity, as well as promoting proper liver function, nerve signaling, and fat metabolism.
• Egg yolk lecithin, a rich source of phosphatidylcholine, contains approximately 78% phosphatidylcholine (PC), 18% phosphatidylethanolamine (PE), and a small amount of cholesterol (2% by weight). This composition provides unique fatty acid profiles, with phosphatidylcholine isolated from egg yolk typically comprising oleic acid (18:1) at around 32%, palmitic acid (16:0) at 33%, stearic acid (18:0) at 11%, and linoleic acid (18:2) at 9%. This specific makeup, predominantly featuring saturated fatty acids and lacking sn-3 polyunsaturated fatty acids (PUFAs), makes egg phosphatidylcholine an ideal model for studying biofilm structures. Its saturation level and stability render it particularly suitable for skincare and cosmetic formulations, where it functions as an effective moisturizer and emulsifier, contributing to the texture and hydrating properties of lotions and creams.
• The unique properties of egg phosphatidylcholine extend to health applications as well. In the elderly, phosphatidylcholine supports enhanced liver function, improved digestion, and better overall cellular health, thus playing a crucial role in maintaining bodily functions that may deteriorate with age. Additionally, its benefits for nerve signaling and cell membrane stability make it an attractive ingredient for supplements targeted at cognitive and liver health. The aging population worldwide is driving demand for such supplements, positioning egg phosphatidylcholine as a key ingredient in products aimed at this demographic.

Market Dynamics and Factors of Egg Phosphatidylcholine Market:

Drivers:

• The growing strong trend for high nutritious food utilization due to the rise in health concerns among consumers should drive egg phosphatidylcholine market size. It is very effective for Alzheimer's, hepatitis C, hepatitis A, peritoneal dialysis, tardive dyskinesia, ulcerative colitis, eczema, weight loss, premenstrual syndrome, and manic-depressive illness. Dietetics is highly used and has observed growth in sales in the past few years.
• Rising awareness of consumers about high-quality cosmetics and nutritious food products is anticipated to accelerate the growth of the global egg phosphatidylcholine market. Macroeconomic factors such as the high rate of urbanization, rising economy, growing per capita income, and employment rate turning the global egg phosphatidylcholine market.
• Growing awareness about health hazards along with growth in the elderly population is expected to drive the market. It caters as an anti-aging supplement and can increase neuroplasticity and improve brainpower. The global old age population over 60 years was estimated at around 900 million in 2015 and is anticipated to increase by 2 billion by 2050. Elderly people are more susceptible to Alzheimer's, memory loss, liver problems, and bone disorders which may support anti-aging demand and promote egg phosphatidylcholine market demand.

Restraints:

• The main restraint factor of this market is the availability of substitutes. This is affected to hamper market growth during the projected period. The accessibility of low-cost substitutes for phosphatidylcholine extraction, such as soybean, sunflower, and mustard, is the main factor that is anticipated to hinder the growth of the global market for egg phosphatidylcholine.

Market Segmentation

• Based on the application, the moisturizer segment accounted for the maximum share.  The moisturizing segment dominated the market due to the high growth of the cosmetics sector. Egg phosphatidylcholine is extensively utilized in the cosmetics industry due to the emulsifying properties of topical creams. The rise in the usage of cosmetics is one of the main reasons for the growth of the moisturizer segment. Properties such as low toxicity and high skin compatibility are the factors boosting the growth of the segment during the forecast period.
• Based on the end-users, the pharmaceuticals segment has dominated the market and is anticipated to continue during the forecast period. This is due to the extensive range of applications in the industry such as the treatment of neurological atherosclerosis and other neurological disorders. The presence of choline in egg phosphatidylcholine is an aid to growth in demand as there is increased consciousness of high-nutrient foods. The Cosmetics segment is expected to grow during the period due to the rise in applications of products and highly increasing industry.

Players Covered in Egg Phosphatidylcholine market are :

• Harmony Whole Foods Market (Canada)
• Avanti Polar Lipids Inc (Alabama)
• Kewpie Corporation (Japan)
• Vitamin Research Products (US)
• NOF America Corporation (US)
• Natural Factors (Canada)
• Jena Bioscience GmbH (Germany)
• Kewpie Corporation (Japan)
• Nutrasal Inc (US)
• Lipoid (Switzerland)
• Others major Players.

Regional Analysis of Egg Phosphatidylcholine Market:

• In North America, the U.S. egg phosphatidylcholine market size is growing due to the presence of dietary supplement producing companies such as Covance, UL and Chubb should drive product demand. The rise in healthy food utilization among the consumers and the FDA's declaration as yolk to be a good source of protein should drive regional industry growth. Moreover, more than one-third of people in the U.S. get affected by cardiovascular disease (CVD) which causes approximately one out of three deaths. Therefore, an increase in the number of CVD among the population owing to red meat ingestion would drive product demand in diet food application.
• In Europe, the region of Germany's egg phosphatidylcholine market size expects to reach above 3%. Growing anti-aging cosmetic and dietetic products demand may drive egg PC market growth. The compound is also approved in liver care programs by doctors and nutritionists turning regional product demand.
• In the Asia Pacific region, China's market size is expected to increase the market owing to China and Japan have about 20 percent and 30 percent of their total population above the 55-year age and 60-year age group respectively. The rising aged population in China and Japan results in growth in skin issues and health disorders. Therefore, growth in the aging population will rise egg PC demand as a medicinal supplement to medicate various diseases.

COVID-19 Impact on Egg Phosphatidylcholine Market:

• Since the COVID-19 pandemic in December 2019, the disease has spread to almost every country across the globe with the World Health Organization declaring it a public health emergency. The global influence of the coronavirus disease 2019 (COVID-19) is already starting to be felt, and will significantly affect the Egg Phosphatidylcholine market in 2020. The outbreak of COVID-19 has brought effects on various aspects, like flight cancellations; travel bans, and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency announced; huge declining of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

Key Industry Developments of Egg Phosphatidylcholine Market:

• In August 2024, Kewpie Corporation (“Kewpie”) is iaunched its new Choline EX, a food with function claims supplement that includes egg yolk choline, which the company has been researching for many years. Egg yolk choline is extracted from egg yolks, and has been reported to maintain verbal memory (the ability to remember and recall words), one of the cognitive functions which deteriorate with age in the middle-aged and elderly. This product is the first commercial food with function claims to include egg yolk choline as its functional substance.

Chapter 1: Introduction
 1.1 Scope and Coverage

Chapter 2:Executive Summary

Chapter 3: Market Landscape
 3.1 Market Dynamics
  3.1.1 Drivers
  3.1.2 Restraints
  3.1.3 Opportunities
  3.1.4 Challenges
 3.2 Market Trend Analysis
 3.3 PESTLE Analysis
 3.4 Porter's Five Forces Analysis
 3.5 Industry Value Chain Analysis
 3.6 Ecosystem
 3.7 Regulatory Landscape
 3.8 Price Trend Analysis
 3.9 Patent Analysis
 3.10 Technology Evolution
 3.11 Investment Pockets
 3.12 Import-Export Analysis

Chapter 4: Egg Phosphatidylcholine Market by Application
 4.1 Egg Phosphatidylcholine Market Snapshot and Growth Engine
 4.2 Egg Phosphatidylcholine Market Overview
 4.3 Emulsifier
  4.3.1 Introduction and Market Overview
  4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.3.3 Key Market Trends, Growth Factors and Opportunities
  4.3.4 Emulsifier: Geographic Segmentation Analysis
 4.4 Solubilizer
  4.4.1 Introduction and Market Overview
  4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.4.3 Key Market Trends, Growth Factors and Opportunities
  4.4.4 Solubilizer: Geographic Segmentation Analysis
 4.5 Moisturizer
  4.5.1 Introduction and Market Overview
  4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.5.3 Key Market Trends, Growth Factors and Opportunities
  4.5.4 Moisturizer: Geographic Segmentation Analysis
 4.6 Others
  4.6.1 Introduction and Market Overview
  4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.6.3 Key Market Trends, Growth Factors and Opportunities
  4.6.4 Others: Geographic Segmentation Analysis

Chapter 5: Egg Phosphatidylcholine Market by End Users
 5.1 Egg Phosphatidylcholine Market Snapshot and Growth Engine
 5.2 Egg Phosphatidylcholine Market Overview
 5.3 Pharmaceuticals & Nutraceuticals
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Pharmaceuticals & Nutraceuticals: Geographic Segmentation Analysis
 5.4 Cosmetics & Personal Care
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Cosmetics & Personal Care: Geographic Segmentation Analysis
 5.5 Dietary Supplements
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 Dietary Supplements: Geographic Segmentation Analysis
 5.6 Others
  5.6.1 Introduction and Market Overview
  5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.6.3 Key Market Trends, Growth Factors and Opportunities
  5.6.4 Others: Geographic Segmentation Analysis

Chapter 6: Company Profiles and Competitive Analysis
 6.1 Competitive Landscape
  6.1.1 Competitive Benchmarking
  6.1.2 Egg Phosphatidylcholine Market Share by Manufacturer (2023)
  6.1.3 Industry BCG Matrix
  6.1.4 Heat Map Analysis
  6.1.5 Mergers and Acquisitions
  
 6.2 HARMONY WHOLE FOODS MARKET (CANADA)
  6.2.1 Company Overview
  6.2.2 Key Executives
  6.2.3 Company Snapshot
  6.2.4 Role of the Company in the Market
  6.2.5 Sustainability and Social Responsibility
  6.2.6 Operating Business Segments
  6.2.7 Product Portfolio
  6.2.8 Business Performance
  6.2.9 Key Strategic Moves and Recent Developments
  6.2.10 SWOT Analysis
 6.3 AVANTI POLAR LIPIDS INC (ALABAMA)
 6.4 KEWPIE CORPORATION (JAPAN)
 6.5 VITAMIN RESEARCH PRODUCTS (US)
 6.6 NOF AMERICA CORPORATION (US)
 6.7 NATURAL FACTORS (CANADA)
 6.8 JENA BIOSCIENCE GMBH (GERMANY)
 6.9 KEWPIE CORPORATION (JAPAN)
 6.10 NUTRASAL INC (US)
 6.11 LIPOID (SWITZERLAND)
 6.12 OTHERS MAJOR PLAYERS.

Chapter 7: Global Egg Phosphatidylcholine Market By Region
 7.1 Overview
 7.2. North America Egg Phosphatidylcholine Market
  7.2.1 Key Market Trends, Growth Factors and Opportunities
  7.2.2 Top Key Companies
  7.2.3 Historic and Forecasted Market Size by Segments
  7.2.4 Historic and Forecasted Market Size By Application
  7.2.4.1 Emulsifier
  7.2.4.2 Solubilizer
  7.2.4.3 Moisturizer
  7.2.4.4 Others
  7.2.5 Historic and Forecasted Market Size By End Users
  7.2.5.1 Pharmaceuticals & Nutraceuticals
  7.2.5.2 Cosmetics & Personal Care
  7.2.5.3 Dietary Supplements
  7.2.5.4 Others
  7.2.6 Historic and Forecast Market Size by Country
  7.2.6.1 US
  7.2.6.2 Canada
  7.2.6.3 Mexico
 7.3. Eastern Europe Egg Phosphatidylcholine Market
  7.3.1 Key Market Trends, Growth Factors and Opportunities
  7.3.2 Top Key Companies
  7.3.3 Historic and Forecasted Market Size by Segments
  7.3.4 Historic and Forecasted Market Size By Application
  7.3.4.1 Emulsifier
  7.3.4.2 Solubilizer
  7.3.4.3 Moisturizer
  7.3.4.4 Others
  7.3.5 Historic and Forecasted Market Size By End Users
  7.3.5.1 Pharmaceuticals & Nutraceuticals
  7.3.5.2 Cosmetics & Personal Care
  7.3.5.3 Dietary Supplements
  7.3.5.4 Others
  7.3.6 Historic and Forecast Market Size by Country
  7.3.6.1 Bulgaria
  7.3.6.2 The Czech Republic
  7.3.6.3 Hungary
  7.3.6.4 Poland
  7.3.6.5 Romania
  7.3.6.6 Rest of Eastern Europe
 7.4. Western Europe Egg Phosphatidylcholine Market
  7.4.1 Key Market Trends, Growth Factors and Opportunities
  7.4.2 Top Key Companies
  7.4.3 Historic and Forecasted Market Size by Segments
  7.4.4 Historic and Forecasted Market Size By Application
  7.4.4.1 Emulsifier
  7.4.4.2 Solubilizer
  7.4.4.3 Moisturizer
  7.4.4.4 Others
  7.4.5 Historic and Forecasted Market Size By End Users
  7.4.5.1 Pharmaceuticals & Nutraceuticals
  7.4.5.2 Cosmetics & Personal Care
  7.4.5.3 Dietary Supplements
  7.4.5.4 Others
  7.4.6 Historic and Forecast Market Size by Country
  7.4.6.1 Germany
  7.4.6.2 UK
  7.4.6.3 France
  7.4.6.4 Netherlands
  7.4.6.5 Italy
  7.4.6.6 Russia
  7.4.6.7 Spain
  7.4.6.8 Rest of Western Europe
 7.5. Asia Pacific Egg Phosphatidylcholine Market
  7.5.1 Key Market Trends, Growth Factors and Opportunities
  7.5.2 Top Key Companies
  7.5.3 Historic and Forecasted Market Size by Segments
  7.5.4 Historic and Forecasted Market Size By Application
  7.5.4.1 Emulsifier
  7.5.4.2 Solubilizer
  7.5.4.3 Moisturizer
  7.5.4.4 Others
  7.5.5 Historic and Forecasted Market Size By End Users
  7.5.5.1 Pharmaceuticals & Nutraceuticals
  7.5.5.2 Cosmetics & Personal Care
  7.5.5.3 Dietary Supplements
  7.5.5.4 Others
  7.5.6 Historic and Forecast Market Size by Country
  7.5.6.1 China
  7.5.6.2 India
  7.5.6.3 Japan
  7.5.6.4 South Korea
  7.5.6.5 Malaysia
  7.5.6.6 Thailand
  7.5.6.7 Vietnam
  7.5.6.8 The Philippines
  7.5.6.9 Australia
  7.5.6.10 New Zealand
  7.5.6.11 Rest of APAC
 7.6. Middle East & Africa Egg Phosphatidylcholine Market
  7.6.1 Key Market Trends, Growth Factors and Opportunities
  7.6.2 Top Key Companies
  7.6.3 Historic and Forecasted Market Size by Segments
  7.6.4 Historic and Forecasted Market Size By Application
  7.6.4.1 Emulsifier
  7.6.4.2 Solubilizer
  7.6.4.3 Moisturizer
  7.6.4.4 Others
  7.6.5 Historic and Forecasted Market Size By End Users
  7.6.5.1 Pharmaceuticals & Nutraceuticals
  7.6.5.2 Cosmetics & Personal Care
  7.6.5.3 Dietary Supplements
  7.6.5.4 Others
  7.6.6 Historic and Forecast Market Size by Country
  7.6.6.1 Turkey
  7.6.6.2 Bahrain
  7.6.6.3 Kuwait
  7.6.6.4 Saudi Arabia
  7.6.6.5 Qatar
  7.6.6.6 UAE
  7.6.6.7 Israel
  7.6.6.8 South Africa
 7.7. South America Egg Phosphatidylcholine Market
  7.7.1 Key Market Trends, Growth Factors and Opportunities
  7.7.2 Top Key Companies
  7.7.3 Historic and Forecasted Market Size by Segments
  7.7.4 Historic and Forecasted Market Size By Application
  7.7.4.1 Emulsifier
  7.7.4.2 Solubilizer
  7.7.4.3 Moisturizer
  7.7.4.4 Others
  7.7.5 Historic and Forecasted Market Size By End Users
  7.7.5.1 Pharmaceuticals & Nutraceuticals
  7.7.5.2 Cosmetics & Personal Care
  7.7.5.3 Dietary Supplements
  7.7.5.4 Others
  7.7.6 Historic and Forecast Market Size by Country
  7.7.6.1 Brazil
  7.7.6.2 Argentina
  7.7.6.3 Rest of SA

Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies

Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research

LIST OF TABLES

TABLE 001. EXECUTIVE SUMMARY
TABLE 002. EGG PHOSPHATIDYLCHOLINE MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. EGG PHOSPHATIDYLCHOLINE MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. EGG PHOSPHATIDYLCHOLINE MARKET COMPETITIVE RIVALRY
TABLE 005. EGG PHOSPHATIDYLCHOLINE MARKET THREAT OF NEW ENTRANTS
TABLE 006. EGG PHOSPHATIDYLCHOLINE MARKET THREAT OF SUBSTITUTES
TABLE 007. EGG PHOSPHATIDYLCHOLINE MARKET BY APPLCATION
TABLE 008. EMULSIFIER MARKET OVERVIEW (2016-2028)
TABLE 009. SOLUBILIZER MARKET OVERVIEW (2016-2028)
TABLE 010. MOISTURIZER MARKET OVERVIEW (2016-2028)
TABLE 011. AND OTHERS MARKET OVERVIEW (2016-2028)
TABLE 012. EGG PHOSPHATIDYLCHOLINE MARKET BY END USE
TABLE 013. PHARMACEUTICALS & NUTRACEUTICALS MARKET OVERVIEW (2016-2028)
TABLE 014. COSMETICS & PERSONAL CARE MARKET OVERVIEW (2016-2028)
TABLE 015. DIETARY SUPPLEMENTS MARKET OVERVIEW (2016-2028)
TABLE 016. AND OTHERS MARKET OVERVIEW (2016-2028)
TABLE 017. NORTH AMERICA EGG PHOSPHATIDYLCHOLINE MARKET, BY APPLCATION (2016-2028)
TABLE 018. NORTH AMERICA EGG PHOSPHATIDYLCHOLINE MARKET, BY END USE (2016-2028)
TABLE 019. N EGG PHOSPHATIDYLCHOLINE MARKET, BY COUNTRY (2016-2028)
TABLE 020. EUROPE EGG PHOSPHATIDYLCHOLINE MARKET, BY APPLCATION (2016-2028)
TABLE 021. EUROPE EGG PHOSPHATIDYLCHOLINE MARKET, BY END USE (2016-2028)
TABLE 022. EGG PHOSPHATIDYLCHOLINE MARKET, BY COUNTRY (2016-2028)
TABLE 023. ASIA PACIFIC EGG PHOSPHATIDYLCHOLINE MARKET, BY APPLCATION (2016-2028)
TABLE 024. ASIA PACIFIC EGG PHOSPHATIDYLCHOLINE MARKET, BY END USE (2016-2028)
TABLE 025. EGG PHOSPHATIDYLCHOLINE MARKET, BY COUNTRY (2016-2028)
TABLE 026. MIDDLE EAST & AFRICA EGG PHOSPHATIDYLCHOLINE MARKET, BY APPLCATION (2016-2028)
TABLE 027. MIDDLE EAST & AFRICA EGG PHOSPHATIDYLCHOLINE MARKET, BY END USE (2016-2028)
TABLE 028. EGG PHOSPHATIDYLCHOLINE MARKET, BY COUNTRY (2016-2028)
TABLE 029. SOUTH AMERICA EGG PHOSPHATIDYLCHOLINE MARKET, BY APPLCATION (2016-2028)
TABLE 030. SOUTH AMERICA EGG PHOSPHATIDYLCHOLINE MARKET, BY END USE (2016-2028)
TABLE 031. EGG PHOSPHATIDYLCHOLINE MARKET, BY COUNTRY (2016-2028)
TABLE 032. HARMONY WHOLE FOODS MARKET (CANADA): SNAPSHOT
TABLE 033. HARMONY WHOLE FOODS MARKET (CANADA): BUSINESS PERFORMANCE
TABLE 034. HARMONY WHOLE FOODS MARKET (CANADA): PRODUCT PORTFOLIO
TABLE 035. HARMONY WHOLE FOODS MARKET (CANADA): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 035. AVANTI POLAR LIPIDS INC (ALABAMA): SNAPSHOT
TABLE 036. AVANTI POLAR LIPIDS INC (ALABAMA): BUSINESS PERFORMANCE
TABLE 037. AVANTI POLAR LIPIDS INC (ALABAMA): PRODUCT PORTFOLIO
TABLE 038. AVANTI POLAR LIPIDS INC (ALABAMA): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 038. KEWPIE CORPORATION (JAPAN): SNAPSHOT
TABLE 039. KEWPIE CORPORATION (JAPAN): BUSINESS PERFORMANCE
TABLE 040. KEWPIE CORPORATION (JAPAN): PRODUCT PORTFOLIO
TABLE 041. KEWPIE CORPORATION (JAPAN): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 041. VITAMIN RESEARCH PRODUCTS (US): SNAPSHOT
TABLE 042. VITAMIN RESEARCH PRODUCTS (US): BUSINESS PERFORMANCE
TABLE 043. VITAMIN RESEARCH PRODUCTS (US): PRODUCT PORTFOLIO
TABLE 044. VITAMIN RESEARCH PRODUCTS (US): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 044. NOF AMERICA CORPORATION (US): SNAPSHOT
TABLE 045. NOF AMERICA CORPORATION (US): BUSINESS PERFORMANCE
TABLE 046. NOF AMERICA CORPORATION (US): PRODUCT PORTFOLIO
TABLE 047. NOF AMERICA CORPORATION (US): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 047. NATURAL FACTORS (CANADA): SNAPSHOT
TABLE 048. NATURAL FACTORS (CANADA): BUSINESS PERFORMANCE
TABLE 049. NATURAL FACTORS (CANADA): PRODUCT PORTFOLIO
TABLE 050. NATURAL FACTORS (CANADA): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 050. JENA BIOSCIENCE GMBH (GERMANY): SNAPSHOT
TABLE 051. JENA BIOSCIENCE GMBH (GERMANY): BUSINESS PERFORMANCE
TABLE 052. JENA BIOSCIENCE GMBH (GERMANY): PRODUCT PORTFOLIO
TABLE 053. JENA BIOSCIENCE GMBH (GERMANY): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 053. KEWPIE CORPORATION (JAPAN): SNAPSHOT
TABLE 054. KEWPIE CORPORATION (JAPAN): BUSINESS PERFORMANCE
TABLE 055. KEWPIE CORPORATION (JAPAN): PRODUCT PORTFOLIO
TABLE 056. KEWPIE CORPORATION (JAPAN): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 056. NUTRASAL INC (US): SNAPSHOT
TABLE 057. NUTRASAL INC (US): BUSINESS PERFORMANCE
TABLE 058. NUTRASAL INC (US): PRODUCT PORTFOLIO
TABLE 059. NUTRASAL INC (US): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 059. LIPOID (SWITZERLAND): SNAPSHOT
TABLE 060. LIPOID (SWITZERLAND): BUSINESS PERFORMANCE
TABLE 061. LIPOID (SWITZERLAND): PRODUCT PORTFOLIO
TABLE 062. LIPOID (SWITZERLAND): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 062. OTHERS: SNAPSHOT
TABLE 063. OTHERS: BUSINESS PERFORMANCE
TABLE 064. OTHERS: PRODUCT PORTFOLIO
TABLE 065. OTHERS: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. EGG PHOSPHATIDYLCHOLINE MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. EGG PHOSPHATIDYLCHOLINE MARKET OVERVIEW BY APPLCATION
FIGURE 012. EMULSIFIER MARKET OVERVIEW (2016-2028)
FIGURE 013. SOLUBILIZER MARKET OVERVIEW (2016-2028)
FIGURE 014. MOISTURIZER MARKET OVERVIEW (2016-2028)
FIGURE 015. AND OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 016. EGG PHOSPHATIDYLCHOLINE MARKET OVERVIEW BY END USE
FIGURE 017. PHARMACEUTICALS & NUTRACEUTICALS MARKET OVERVIEW (2016-2028)
FIGURE 018. COSMETICS & PERSONAL CARE MARKET OVERVIEW (2016-2028)
FIGURE 019. DIETARY SUPPLEMENTS MARKET OVERVIEW (2016-2028)
FIGURE 020. AND OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 021. NORTH AMERICA EGG PHOSPHATIDYLCHOLINE MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 022. EUROPE EGG PHOSPHATIDYLCHOLINE MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 023. ASIA PACIFIC EGG PHOSPHATIDYLCHOLINE MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 024. MIDDLE EAST & AFRICA EGG PHOSPHATIDYLCHOLINE MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 025. SOUTH AMERICA EGG PHOSPHATIDYLCHOLINE MARKET OVERVIEW BY COUNTRY (2016-2028)